| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +0.00% | +2.93% | +1.21% | +1.72% | +1.72% | — |
| 14d | 2 | +50.00% | +0.89% | +1.22% | -0.33% | -0.33% | — |
| 30d | 2 | +100.00% | -23.31% | +2.37% | -25.67% | -25.67% | — |
| 60d | 2 | +100.00% | -18.43% | -0.28% | -18.14% | -18.14% | — |
| 90d | 2 | +100.00% | -20.61% | -3.58% | -17.04% | -17.04% | — |
| 180d | 2 | +50.00% | -16.70% | +7.64% | -24.34% | -24.34% | — |
| 1y | 2(1 pending) | +100.00% | -37.20% | +17.20% | -54.40% | -54.40% | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| XLO XILIO THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 1,826 | $0.64 | $1.2K | 6,371 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | SALE SVP, FINANCE AND ACCOUNTING | 5,000 | — | — | 10,000 | Jan 1, 2026 | Jan 5, 2026 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASE SVP, FINANCE AND ACCOUNTING | 5,000 | — | — | 8,197 | Jan 1, 2026 | Jan 5, 2026 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 95,221 | — | — | 95,221 | Dec 31, 2025 | Jan 5, 2026 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | SALE SVP, FINANCE AND ACCOUNTING | 55,000 | — | — | 0 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 55,000 | — | — | 55,000 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 131,700 | — | — | 131,700 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | SALE SVP, FINANCE AND ACCOUNTING | 25,000 | — | — | 0 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | SALE SVP, FINANCE AND ACCOUNTING | 20,000 | — | — | 0 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 20,000 | — | — | 20,000 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 25,000 | — | — | 25,000 | Nov 21, 2025 | Nov 25, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 1,803 | $0.98 | $1.8K | 3,197 | Jan 2, 2025 | Jan 3, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 60,000 | — | — | 60,000 | Jan 1, 2025 | Jan 3, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASE SVP, FINANCE AND ACCOUNTING | 5,000 | — | — | 5,000 | Jan 1, 2025 | Jan 3, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | SALE SVP, FINANCE AND ACCOUNTING | 5,000 | — | — | 15,000 | Jan 1, 2025 | Jan 3, 2025 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 26,000 | — | — | 26,000 | Oct 1, 2024 | Oct 2, 2024 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 20,000 | — | — | 20,000 | May 1, 2024 | May 3, 2024 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 20,000 | — | — | 20,000 | Jan 1, 2024 | Jan 3, 2024 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 25,000 | — | — | 25,000 | Aug 16, 2023 | Aug 18, 2023 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 55,000 | — | — | 55,000 | Apr 1, 2023 | Apr 3, 2023 ↗ | View → |